Amorolfine Hydrochloride

Broad spectrum topical antimycotic morpholine antifungal drug that inhibits fungal sterol synthesis.

Tinea pedis, Tinea cruris, Tinea inguinalis, Tinea corporis, Tinea manuum, Pityriasis versicolor.

Topical Antifungal preparations

Morpholine Antifungal

Inhibits fungal enzymes D14 reductase and D7-D8 isomerase, depleting ergosterol and disrupting cell membrane.

Interferes with fungal sterol synthesis pathway, leading to fungal cell lysis.

Applied to affected skin areas once daily in the evening after cleansing for 2-3 weeks, or up to 6 weeks for foot mycoses.

Topical application only. Avoid contact with eyes, ears, and mucous membranes.

Apply as soon as remembered.

Adverse skin reactions are rare and mostly mild.

Avoid contact with eyes, ears, and mucous membranes. Stop immediately if allergic reaction occurs.

Hypersensitivity to amorolfine or any excipients.

No specific studies involving concomitant treatment with other topical medicines.

Not applicable.

Should not be used during pregnancy unless clearly necessary.

Pregnancy Category: Consult Doctor — always consult a doctor before taking during pregnancy.

Should not be used during lactation; breastfeeding women must not use in the breast area.

Not recommended in children due to lack of clinical experience.

Use as directed by the physician.

No specific restrictions.

In case of accidental oral ingestion, perform gastric emptying.

Keep below 30°C, away from light & moisture. Keep out of reach of children.

Amorolfine hydrochloride organic compound